
NYSE:XYL
This summary was created by AI, based on 2 opinions in the last 12 months.
Xylem Inc. (XYL-N) appears to be a promising investment opportunity due to its pivotal role in the global water management sector. The company operates in a market where water scarcity is becoming increasingly critical, with only a small fraction of the world's water being drinkable. Expert reviews indicate that the stock is a solid buy despite recent fluctuations, with one expert highlighting its potential for future growth and the need for ongoing upgrades to water infrastructure globally. While the stock has recently broken out, there may be a potential for a pullback, suggesting that current investors could benefit from holding their position or even adding to it on dips. Overall, the long-term outlook remains positive as the demand for innovative water solutions continues to rise.
This was a spin out from ITT Corp in 2011. They make water equipment and sources to the water industry. Their products encompass anywhere from water transportation (pumps, valves, controls), treatment and testing. Their end markets include municipalities, utilities, industrial clients, building services, commercial clients, and even the agricultural industry. 70% of the globe is made up of water, but only 1% is actually drinkable or potable. There is the issue of emerging markets, where they are still building out their water infrastructure. In the developed markets, there is the problem of aging infrastructure which needs replacement. Dividend yield of 1.26%. (Analysts’ price target is $53.58.)
They are in the business of transportation, testing and treatment of water. Drinkable water is a very scarce commodity. 21% of revenues are from emerging markets. They are trying to give people access to sanitation. In the US there is a lot of overhaul required on the existing systems. In 2012 state governments cut back because there was no funding. XYL-N also have exposure in the UK. They just acquired a smart metering company and will do some cross selling. (Analysts’ target: $54.00).